Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 02, 2021

SELL
$59.17 - $69.31 $386,498 - $452,732
-6,532 Closed
0 $0
Q4 2019

Jan 31, 2020

BUY
$49.21 - $64.19 $3,936 - $5,135
80 Added 1.24%
6,532 $419,000
Q2 2017

Aug 07, 2017

BUY
N/A
6,452
6,452 $360,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Provident Trust CO Portfolio

Follow Provident Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Provident Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Provident Trust CO with notifications on news.